FI78838C - Foerfarande foer framstaellning av stabiliserade insulinpreparat. - Google Patents

Foerfarande foer framstaellning av stabiliserade insulinpreparat. Download PDF

Info

Publication number
FI78838C
FI78838C FI820808A FI820808A FI78838C FI 78838 C FI78838 C FI 78838C FI 820808 A FI820808 A FI 820808A FI 820808 A FI820808 A FI 820808A FI 78838 C FI78838 C FI 78838C
Authority
FI
Finland
Prior art keywords
insulin
calcium
magnesium
solution
concentration
Prior art date
Application number
FI820808A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI820808L (fi
FI78838B (fi
Inventor
Svend Havelund
Jens Joergen Veilgaard Brange
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI820808L publication Critical patent/FI820808L/fi
Publication of FI78838B publication Critical patent/FI78838B/fi
Application granted granted Critical
Publication of FI78838C publication Critical patent/FI78838C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Preparations (AREA)
FI820808A 1981-03-10 1982-03-09 Foerfarande foer framstaellning av stabiliserade insulinpreparat. FI78838C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8107423 1981-03-10
GB8107423 1981-03-10
DK414381 1981-09-18
DK414381 1981-09-18

Publications (3)

Publication Number Publication Date
FI820808L FI820808L (fi) 1982-09-11
FI78838B FI78838B (fi) 1989-06-30
FI78838C true FI78838C (fi) 1989-10-10

Family

ID=26067363

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820808A FI78838C (fi) 1981-03-10 1982-03-09 Foerfarande foer framstaellning av stabiliserade insulinpreparat.

Country Status (14)

Country Link
US (1) US4472385A (enExample)
EP (1) EP0060141B1 (enExample)
AT (1) ATE23269T1 (enExample)
AU (1) AU550068B2 (enExample)
CA (1) CA1170990A (enExample)
CH (1) CH652031A5 (enExample)
DE (1) DE3274064D1 (enExample)
ES (1) ES510245A0 (enExample)
FI (1) FI78838C (enExample)
FR (1) FR2501507B1 (enExample)
GB (1) GB2094145B (enExample)
IE (1) IE52904B1 (enExample)
IT (1) IT1150639B (enExample)
NO (1) NO157843C (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485580D1 (de) * 1983-12-16 1992-04-16 Aoki Thomas Takemi Sacramento Algorithmus zur verabreichung von insulin.
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
DE10075034I1 (de) * 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE69708121T3 (de) † 1996-06-20 2012-05-16 Novo Nordisk A/S Halogenid-enthaltende insulinzubereitungen
AR012894A1 (es) 1997-06-13 2000-11-22 Lilly Co Eli Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
WO1999034821A1 (en) * 1998-01-09 1999-07-15 Novo Nordisk A/S Stabilised insulin compositions
US20020156434A1 (en) * 1998-03-13 2002-10-24 Minimed Inc. Stabilizing catheter for protein drug delivery
DE60335797D1 (de) 2002-05-07 2011-03-03 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
US20030226223A1 (en) 2002-06-11 2003-12-11 The Procter & Gamble Co. High efficiency electric toothbrush
US7322066B2 (en) 2003-07-16 2008-01-29 Church & Dwight Co., Inc. Electric toothbrushes having movable, intermittently movable, and fixed bristles
US20050053895A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Attention: Chief Patent Counsel Illuminated electric toothbrushes emitting high luminous intensity toothbrush
US20050050659A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Electric toothbrush comprising an electrically powered element
FR2896164B1 (fr) * 2006-01-18 2008-07-04 Flamel Technologies Sa Formulation colloidale d'insuline longue action et sa preparation
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
US20150273022A1 (en) * 2014-02-10 2015-10-01 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR892194A (fr) * 1938-06-29 1944-03-30 Ig Farbenindustrie Ag Procédé de fabrication de préparations à base d'insuline
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states

Also Published As

Publication number Publication date
NO157843B (no) 1988-02-22
ATE23269T1 (de) 1986-11-15
DE3274064D1 (en) 1986-12-11
IT1150639B (it) 1986-12-17
IE820536L (en) 1982-09-10
FR2501507A1 (enExample) 1982-09-17
FI820808L (fi) 1982-09-11
IE52904B1 (en) 1988-04-13
GB2094145B (en) 1984-12-05
IT8220038A0 (it) 1982-03-09
EP0060141B1 (en) 1986-11-05
NO157843C (no) 1988-06-01
ES8302462A1 (es) 1983-01-16
CH652031A5 (de) 1985-10-31
EP0060141A3 (en) 1983-08-24
AU8111482A (en) 1982-09-16
GB2094145A (en) 1982-09-15
FR2501507B1 (enExample) 1986-04-18
FI78838B (fi) 1989-06-30
EP0060141A2 (en) 1982-09-15
US4472385A (en) 1984-09-18
AU550068B2 (en) 1986-02-27
NO820742L (no) 1982-09-13
CA1170990A (en) 1984-07-17
ES510245A0 (es) 1983-01-16

Similar Documents

Publication Publication Date Title
FI78838C (fi) Foerfarande foer framstaellning av stabiliserade insulinpreparat.
US4476118A (en) Stabilized insulin preparations
EP1506230B1 (en) Soluble formulations comprising monomeric insulin and acylated insulin
HU201475B (en) Process for producing liquide insulin compositions
EP2123270B2 (en) Iron metabolism-improving agent
NZ202328A (en) Insulin solutions containing phospholipid stabiliser
NO173279B (no) Fremgangsmaate for fremstilling av et stabilt zink-protamin-alfa-interferonkompleks
EP3369429B1 (en) Pharmaceutical composition intended to be administered to nasal mucosa
EP1946763B1 (en) Promoter for recovery from anesthesia
CN107106659B (zh) 肠胃外胰高血糖素制剂
JP2563336B2 (ja) 角膜透過促進点眼剤
CA1252717A (en) Buffered polyol-hormone mixture for use in chronic parenteral hormone administration
US10213452B2 (en) Pharmaceutical compositions containing steviosides
WO2015131902A1 (en) Novel fast acting insulin preparations
DK149833B (da) Fremgangsmaade til fremstilling af et oploest zinkinsulinpraeparat, derer fysisk stabilt
DK150813B (da) Fremgangsmaade til fremstilling af stabiliserede insulinoploesninger
KR102244530B1 (ko) 뇌 및 전신의 재관류 손상을 예방하거나 감소시키기 위한 보호 용액
CN119405787A (zh) 一种高稳定性的高浓度含锌胰岛素制剂
WO2009128357A1 (ja) 生理活性蛋白質含有ナノ粒子組成物およびその製造方法
JP3643879B2 (ja) 電解質輸液組成物
RU2252752C2 (ru) Готовая лекарственная форма инсулина человека короткого действия
Hõgenauer et al. Discrepancies between effects of recombinant human growth hormone on absorption and secretion of water and electrolytes on the human jejunum compared to results reported on rat jejunum
KR20190111784A (ko) 프레가발린 함유 조성물의 제조 방법 및 프레가발린 함유 조성물
WO2006096079A2 (en) Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus.
BE892413A (fr) Preparation d'insuline stabilisee et procede pour leur fabrication

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NOVO INDUSTRI A/S